Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-28

Clinical Trial Update: Dexamethasone in Cryptococcal Meningitis [Phase 2]

View source ↗

Summary

Phase 2 trial update on dexamethasone for cryptococcal meningitis, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Meningitis, Cryptococcal, HIV Infections | Phase 2 | Status: COMPLETED